Sisyphean Efforts: Establishing the Correct Risk-Benefit Balance for Adjuvant Therapies

被引：1

作者：

Bergh, Jonas ^{[1
,2
]}

Pritchard, Kathleen I. ^{[3
,4
]}

Cameron, David ^{[5
]}

机构：

[1] Karolinska Inst, Stockholm, Sweden

[2] St Gorans Univ Hosp, S-11281 Stockholm, Sweden

[3] Sunnybrook Odette Canc Ctr, Toronto, ON, Canada

[4] Univ Toronto, Toronto, ON, Canada

[5] Univ Edinburgh, Canc Res Ctr, Edinburgh, Midlothian, Scotland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 09期

关键词：

PATIENT-LEVEL METAANALYSIS; BREAST-CANCER; ESTROGEN-RECEPTOR; FOLLOW-UP; TAMOXIFEN; RADIOTHERAPY; SUPPRESSION; RECURRENCE; WOMEN;

D O I：

10.1200/JCO.2015.65.2255

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：895 / +

页数：5

共 21 条

[1]

Abe O, 1998, LANCET, V352, P930

[2] Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials [J].

Albain, K. ;

Anderson, S. ;

Arriagada, R. ;

Barlow, W. ;

Bergh, J. ;

Bliss, J. ;

Buyse, M. ;

Cameron, D. ;

Carrasco, E. ;

Clarke, M. ;

Correa, C. ;

Coates, A. ;

Collins, R. ;

Costantino, J. ;

Cutter, D. ;

Cuzick, J. ;

Darby, S. ;

Davidson, N. ;

Davies, C. ;

Davies, K. ;

Delmestri, A. ;

Di Leo, A. ;

Dowsett, M. ;

Elphinstone, P. ;

Evans, V. ;

Ewertz, M. ;

Gelber, R. ;

Gettins, L. ;

Geyer, C. ;

Goldhirsch, A. ;

Godwin, J. ;

Gray, R. ;

Gregory, C. ;

Hayes, D. ;

Hill, C. ;

Ingle, J. ;

Jakesz, R. ;

James, S. ;

Kaufmann, M. ;

Kerr, A. ;

MacKinnon, E. ;

McGale, P. ;

McHugh, T. ;

Norton, L. ;

Ohashi, Y. ;

Paik, S. ;

Pan, H. C. ;

Perez, E. ;

Peto, R. ;

Piccart, M. .

LANCET, 2012, 379 (9814) :432-444

[3] Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER) [J].

Andre, Fabrice ;

Bachelot, Thomas ;

Commo, Frederic ;

Campone, Mario ;

Arnedos, Monica ;

Dieras, Veronique ;

Lacroix-Triki, Magali ;

Lacroix, Ludovic ;

Cohen, Pascale ;

Gentien, David ;

Adelaide, Jose ;

Dalenc, Florence ;

Goncalves, Anthony ;

Levy, Christelle ;

Ferrero, Jean-Marc ;

Bonneterre, Jacques ;

Lefeuvre, Claudia ;

Jimenez, Marta ;

Filleron, Thomas ;

Bonnefoi, Herve .

LANCET ONCOLOGY, 2014, 15 (03) :267-274

[4]

[Anonymous], 1988, NEW ENGL J MED, V319, P1681

[5]

Clarke M, 1998, LANCET, V351, P1451

[6] Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials [J].

Coleman, R. ;

Powles, T. ;

Paterson, A. ;

Gnant, M. ;

Anderson, S. ;

Diel, I. ;

Gralow, J. ;

von Minckwitz, G. ;

Moebus, V. ;

Bergh, J. ;

Pritchard, K. I. ;

Bliss, J. ;

Cameron, D. ;

Evans, V. ;

Pan, H. ;

Peto, R. ;

Bradley, R. ;

Gray, R. ;

Bartsch, R. ;

Dubsky, P. ;

Fesl, C. ;

Fohler, H. ;

Greil, R. ;

Jakesz, R. ;

Lang, A. ;

Luschin-Ebengreuth, G. ;

Marth, C. ;

Mlineritsch, B. ;

Samonigg, H. ;

Singer, C. F. ;

Steger, G. G. ;

Stoeger, H. ;

Olivotto, I. ;

Ragaz, J. ;

Christiansen, P. ;

Ejlertsen, B. ;

Ewertz, M. ;

Jensen, M-B ;

Moller, S. ;

Mouridsen, H. T. ;

Eiermann, W. ;

Hilfrich, J. ;

Jonat, W. ;

Kaufmann, M. ;

Kreienberg, R. ;

Schumacher, M. ;

Blohmer, J. U. ;

Costa, S. D. ;

Eidtmann, H. ;

Gerber, B. .

LANCET, 2015, 386 (10001) :1353-1361

[7] Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V [J].

Colleoni, Marco ;

Sun, Zhuoxin ;

Price, Karen N. ;

Karlsson, Per ;

Forbes, John F. ;

Thurlimann, Beat ;

Gianni, Lorenzo ;

Castiglione, Monica ;

Gelber, Richard D. ;

Coates, Alan S. ;

Goldhirsch, Aron .

JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (09) :927-+

[8] Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer [J].

Darby, Sarah C. ;

Ewertz, Marianne ;

McGale, Paul ;

Bennet, Anna M. ;

Blom-Goldman, Ulla ;

Bronnum, Dorthe ;

Correa, Candace ;

Cutter, David ;

Gagliardi, Giovanna ;

Gigante, Bruna ;

Jensen, Maj-Britt ;

Nisbet, Andrew ;

Peto, Richard ;

Rahimi, Kazem ;

Taylor, Carolyn ;

Hall, Per .

NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (11) :987-998

[9] Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials [J].

Davies, C. ;

Godwin, J. ;

Gray, R. ;

Clarke, M. ;

Darby, S. ;

McGale, P. ;

Wang, Y. C. ;

Peto, R. ;

Pan, H. C. ;

Cutter, D. ;

Taylor, C. ;

Ingle, J. .

LANCET, 2011, 378 (9793) :771-784

[10] Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial [J].

Davies, Christina ;

Pan, Hongchao ;

Godwin, Jon ;

Gray, Richard ;

Arriagada, Rodrigo ;

Raina, Vinod ;

Abraham, Mirta ;

Medeiros Alencar, Victor Hugo ;

Badran, Atef ;

Bonfill, Xavier ;

Bradbury, Joan ;

Clarke, Michael ;

Collins, Rory ;

Davis, Susan R. ;

Delmestri, Antonella ;

Forbes, John F. ;

Haddad, Peiman ;

Hou, Ming-Feng ;

Inbar, Moshe ;

Khaled, Hussein ;

Kielanowska, Joanna ;

Kwan, Wing-Hong ;

Mathew, Beela S. ;

Mittra, Indraneel ;

Mueller, Bettina ;

Nicolucci, Antonio ;

Peralta, Octavio ;

Pernas, Fany ;

Petruzelka, Lubos ;

Pienkowski, Tadeusz ;

Radhika, Ramachandran ;

Rajan, Balakrishnan ;

Rubach, Maryna T. ;

Tort, Sera ;

Urrutia, Gerard ;

Valentini, Miriam ;

Wang, Yaochen ;

Peto, Richard .

LANCET, 2013, 381 (9869) :805-816

← 1 2 3 →